Received Mar 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
Expired dose given; This non-serious case was reported by a other health professional via sales rep and described the occurrence of expired vaccine used in a 13-year-old patient who received HBV (Engerix B Junior) (expiry date 09-MAR-2025) for prophylaxis. On 18-MAR-2025, the patient received the 2nd dose of Engerix B Junior. On 18-MAR-2025, an unknown time after receiving Engerix B Junior, the patient experienced expired vaccine used (Verbatim: Expired dose given). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 18-MAR-2025 A field representative called in stating that had called in requesting data about the administration of a Engerix-B after an expired dose was administered with the dose having expired, which led to expired vaccine used.